Efficacy and safety of therapies for COVID-19 in pregnancy: a systematic review and meta-analysis
Description
CONCLUSIONS: To our analysis, CAS/IMD, remdesivir, and IFN alpha 2b reduced the number of cesarean sections but demonstrated no effect on disease progression and other obstetric and COVID-19 related outcomes. The inability to evaluate the influence
